Nutex Health
NUTX
129 hedge funds and large institutions have $266M invested in Nutex Health in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 25 closing their positions.
96% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 26
60% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 25
10% more funds holding
Funds holding: 117 → 129 (+12)
3.06% more ownership
Funds ownership: 37.13% → 40.19% (+3.1%)
38% less capital invested
Capital invested by funds: $432M → $266M (-$166M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$8.76M |
| 3 |
WC
Winmill & Co
Rochester,
New York
|
+$8.01M |
| 4 |
PP
Pertento Partners
London,
United Kingdom
|
+$6.08M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Topline Capital Management
Santa Monica,
California
|
-$61M |
| 2 |
PCM
Penserra Capital Management
Orinda,
California
|
-$2.77M |
| 3 |
Lazard Asset Management
New York
|
-$2.32M |
| 4 |
Morgan Stanley
New York
|
-$1.86M |
| 5 |
Jane Street
New York
|
-$1.3M |
NUTX Hedge Fund Activity: Q1 2026 in Review
129 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q1 2026, worth a combined $266M — down 38% from $432M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new NUTX positions and 25 closed out — a net gain of 15 holders — while 51 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $12M. The largest seller was Topline Capital Management, cutting an estimated $61M.
- 129 institutional investors held Nutex Health (NUTX) as of Q1 2026, up from 117 in Q4 2025.
- Funds reported $266M of Nutex Health stock for Q1 2026, down 38% quarter-over-quarter.
- 40 funds opened new Nutex Health positions in Q1 2026 and 25 closed out, a net change of +15 holders.
- The largest Nutex Health buyer in Q1 2026 was BlackRock, an estimated $12M added.
- The largest Nutex Health seller in Q1 2026 was Topline Capital Management, an estimated $61M sold.
Based on aggregated 13F filings for Q1 2026.